Study of TP-04 in Participants With Papulopustular Rosacea
Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This study is being done to evaluate the safety, tolerability, and efficacy of the study
drug, TP-04, in participants with papulopustular rosacea (PPR).